Tag Archives: RXII

The Year In Spinoffs – 2012 Best And Worst

Another year has come and gone which means that we have all been inundated with a million ‘Look Back’ and ‘Best Of/Worst Of’ pieces for the past few weeks. I always found this to be an interesting and immensely boring phenomenon as we just lived through it. Should be pretty fresh in our memories. We are nothing but… Read More »

Galena Dividend Of RXI Expected Today

After a little drama, Galena Biopharma (GALE) will pay out a dividend of one share of Rxi Pharmaceutical for every share of GALE owned. The dividend is being paid out at the close of business today to shareholders as of the April 23rd record date. The new company will trade OTC under the ticker RXII in the coming… Read More »

Galena Spin Delayed…But For How Long?

In an earlier post, we noted that Galena Biopharma’s (GALE) planned spinoff of Rxi Pharmaceutical was still awaiting approval and that the actual distribution date had yet to be determined despite a date of record being established. You can scratch that date off your calendar as the company filed an 8-K on April 10th announcing that it had… Read More »

Galena Biopharma Divvying Up Its RNA Business

Who says you have to be a mega-conglomerate in order to pursue a spinoff? Galena Biopharma (GALE), a $46m market cap biotech company, announced that it will spin off RXi Pharmaceutical via stock dividend sometime in the coming months. While the board has not set a final payment date, the date of record will be March 8, 2012… Read More »